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Abstract Receptor aggregation is believed to be an important, 
early step when growth factors such as PDGF stimulate 
proliferation and differentiation of cell populations. To investi-
gate receptor aggregation, we utilized a novel biophysical 
technique, image correlation spectroscopy, to study the distribu-
tion and aggregation state of PDGF-ß receptors on the surface of 
human dermal fibroblasts under various experimental conditions. 
It was found that the cell surface receptors were pre-clustered at 
4°C and receptor aggregation increased for samples measured at 
37°C. Treatment with PDGF-BB had no measurable effect on 
the receptor aggregation state. The results also indícate that 
additions of 10% serum or an inhibitor of tyrosine kinase 
activity, may disperse the receptors. The results of this study are 
consistent with organization of PDGF-ß receptors in pre-existing 
membrane domains. 
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1. Introduction 
Platelet-derived growth factor (PDGF) is a major mitogen 
in serum for cultured mesenchymal, smooth muscle and glial 
cells. It consists of two, disulfide-linked polypeptide chains, 
denoted A and B [1], which share 60% homology in their 
amino acid sequences [2-5]. Three dimeric forms of PDGF 
exist, viz. PDGF-AA, -AB and -BB, with different functional 
activities. Two distinct, but structurally related PDGF recep-
tors have been characterized, i.e. the a-receptor and ß-recep-
tor [6-9]. The a-receptor binds all three forms of PDGF, 
whereas the ß-receptor binds primarily PDGF-BB, and with 
lower affinity PDGF-AB. The mechanism by which PDGF 
exerts its growth factor promoting activity is not fully under-
stood. A number of metabolic changes have been documented 
to occur rapidly following addition of PDGF. They include 
receptor autophosphorylation on tyrosine residues, hydrolysis 
of plasma membrane phospholipids, increase in intracellular 
free [Ca2+], activation of protein kinase C (PKC) and of Na+ / 
H + exchange, alterations in the structure and organization of 
cytoskeletal proteins, and changes in gene expression [10-12]. 
Intra- and intermolecular models of ligand-dependent 
growth factor kinase activation have been proposed and are 
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widely discussed [13-15]. The combination of biophysical and 
biochemical experiments have provided important under-
standing of the mechanism(s) behind the action of growth 
factor receptors and associated cell signals [5,13]. 
To elucidate basal mobility characteristics of the PDGF 
receptor in the fibroblast membrane, and to investigate the 
effects of serum and PDGF stimulation, experiments were 
conducted [16,17] utilizing the previously described technique 
of fluorescence recovery after photobleaching (FRAP) [18-20]. 
Using this method, it is possible to measure the rate of lateral 
diffusion and estimate the fraction of mobile PDGF receptors 
in human fibroblasts. We have recently employed a new tech-
nique, image correlation spectroscopy (ICS) [21], a further 
development of scanning-fluorescence correlation spectros-
copy [22], to characterize the distribution and state of aggre-
gation of membrane receptors, specifically PDGF-ß receptors. 
The present report describes ICS analysis of PDGF-ß receptor 
clustering at 4 and 37°C, and as affected by PDGF-BB, serum 
and tyrosine kinase inhibition treatments. 
A major reason for studying membrane receptor dynamics 
and surface distributions is their relevance to biological func-
tion of receptors at a molecular level. Evidence has accumu-
lated that the molecular organization and lateral distribution 
of receptors in cell membranes are important for their func-
tion [13,23,24]. It is possible that most receptors are neither 
randomly nor homogeneously distributed, but rather partly 
aggregated. Moreover, the distribution of receptors on the 
cell surface often changes as a consequence of receptor-ligand 
interactions [25]. Obvious questions to be answered are there-
fore: Are the receptors uniformly or randomly distributed? 
Do they reside within domains on the cell surface prior to 
the binding of ligand? If clusters exist, can their surface den-
sity and size be determined? What are their lateral mobilities? 
Answers to these and related questions will influence the way 
we understand the dependence of cellular response on changes 
in receptor mobility, receptor-receptor interactions and recep-
tor-ligand interactions. 
2. Materials and methods 
2.1. Cell culture 
Human foreskin fibroblasts (AG1523; Human Genetic Cell Repos-
itory, Camden, NJ) were maintained at 37°C in a humidified incuba-
tor at 5% CO2 (type CCvAutoZero; Hereus, Hanau, Germany) in 
Eagle's minimum essential medium (Gibco Ltd., Paisley, UK) supple-
mented with 10% fetal calf serum, penicillin (50 IU/ml) and strepto-
mycin (50 ug/ml). The cells were sub-cultured on 12 mm glass cover-
slips in Petri dishes, both in the same type of medium to yield 
'normal' cells, and in MCDB 105 medium (Gibco, Ltd.) with 1 mg/ 
ml serum albumin added after 3 days to yield 'starved' cells, i.e. cells 
from serum-free growth conditions. In all cases the cells were used on 
day 5 after plating. 
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2.2. Cell labeling 
Monoclonal antibodies directed specifically toward the PDGF-ß 
receptor (PDGFR-B2) [26] were either kindly provided by Dr. C.-H. 
Heldin, Ludwig Institute for Cancer Research, Uppsala, Sweden, or 
purchased from Sigma Chemical Co. (no. P-7679, St. Louis, MO). 
The antibody has been shown to bind to the extracellular part of 
the PDGF-ß receptor. It does not inhibit 125I-PDGF binding to the 
receptor, but does precipitate the receptor in suspension. On cells the 
antibody induces receptor patches. An FITC-labeled goat-anti-mouse 
IgG antibody, specific for the Fc portion of the mouse monoclonal 
antibody (no. F-5387, Sigma Chemical Co., St. Louis, MO) was used 
as a secondary antibody. The cells were first pre-incubated at 37°C for 
10 min, and then incubated successively with the primary and second-
ary antibodies for 30 min on ice. The primary antibodies were used at 
a 1:10 dilution from stock concentration and the secondary antibodies 
at a 1:5 dilution for labeling purposes to ensure saturating labeling 
conditions. Before addition of the secondary antibody, the cells were 
washed in Krebs-Ringer glucose-containing phosphate buffer with 10 
mM glucose and 1 mM Ca2+ and Mg2+, pH 7.3, KRG. PDGF-BB 
was a kind gift from Dr. C.-H. Heldin. Some samples were treated 
with 20 ng/ml PDGF-BB following immunolabeling of the cells. In 
separate experiments the growth factor was demonstrated to be active 
at concentrations as low as 1 ng/ml on AG1523 cells (data not 
shown). The erbstatin analog was a product of Calbiochem-Novabio-
chem Corp. (San Diego, CA). To achieve inhibition of tyrosine phos-
phorylation, some cells were preincubated with 5 |xg/ml erbstatin ana-
log, for 10 min at 37°C. The medium was then removed and the cells 
put on ice before the labeling procedure. Erbstatin analog was present 
during the measurements. 
2.3. Image correlation spectroscopy (ICS) 
The theoretical and experimental basis for ICS has recently been 
presented [21]. Briefly, the surface distribution of fluorescently stained 
PDGF-ß receptors was measured via confocal laser scanning micros-
copy (CLSM) [27] using a Phoibos 1000 microscope (Molecular Dy-
namics, Sunnyvale, CA). ICS analysis was carried out on confocal 
images which were obtained at the highest possible magnification 
using a 100X, 1.3 N.A. objective, yielding a pixel resolution of 0.1 
Urn in both the x- and ^-directions (Fig. IB). These 'high magnifica-
tion' images were collected to ensure that none of the areas outside of 
the cell (as visible in Fig. 1A) were sampled. The high zoom confocal 
images were utilized for autocorrelation analysis, and were transferred 
electronically from the Silicon Graphics Iris Indigo workstation of the 
Phoibos 1000 microscope in Linköping to a VAX 6430 mainframe 
computer at the Information Technology Services of the University 
of Western Ontario (London, ON, Canada). ICS programs were im-
plemented on the VAX mainframe to calculate a two-dimensional 
spatial autocorrelation function from each confocal image. The zero 
lag (central) amplitude of the resulting discrete autocorrelation func-
tion (the g(0,0) value) was determined via a non-linear least-squares 
fitting procedure (Fig. 1C). As has been described previously, the 
g(0,0) value is in fact the average number of independent fluorescent 
entities within an area defined by the focused laser beam on the cell 
surface [21]. The average surface density of labeled receptors (the 
cluster density) is then directly calculated via a simple conversion 
factor from the g(0,0) value and the focal spot area of the laser 
beam (the beam area is calculable from the laser beam radius which 
is also obtained as a parameter from the fitting to the autocorrelation 
data) [21]. 
3. Results 
3.1. Effect of temperature and PDGF-BB on PDGFR-$ 
aggregation 
To study the effect of PDGF and temperature independ-
ently, live cells were labeled at 4°C, then transferred to a 
temperature-controlled microscope stage (4 ± 0.2°C), where 
PDGF-BB was added after 5 min. The spatial distribution 
of the labeled receptors was then recorded by scanning a 
confocal image at a fixed optical plane on a specific area of 
the membrane of an individual cell. A time series of confocal 
images was collected from an individual sample at 5-min in-
tervals for a total of 35 min with a different cell being imaged 
for each sample time. Multiple time series were collected on 
identically prepared samples. The mean surface density of 
labeled receptors in each image (the receptor cluster density) 
was calculated using the ICS technique as described above. 
The average number of receptor clusters varied between 8 and 
12 per um2 (Fig. 2A). Each time point is the average of 11-19 
different samples obtained on 4—5 occasions. No effect of 
PDGF-BB addition was seen. The frequency distribution of 
cluster densities for these samples is shown in Fig. 3A. As 
images are sampled from individual cells, the frequency dis-
tribution reflects a sampling of the inherent variation in clus-
ter density in the cell population. A large variation in cluster 
density among individual cells is detected. 
In the second set of experiments, the stage temperature was 
increased to 37(±0.2°C), and PDGF-BB was again added 
after 5 min. In this case, the cluster density was a factor 3 -
4 lower, i.e. around 3^1 clusters per u\m2 (Fig. 2B). No sta-
tistically significant effect of PDGF-BB was observed, 
although the cluster density decreased gradually with time 
after addition of PDGF-BB. The frequency distribution of 
the cluster densities for the intact cells at 37°C is presented 
in Fig. 3C and is much narrower than that for the cells at 4°C. 
This reflects a more homogeneous receptor aggregation state 
for the cell population at the higher temperature. 
3.2. Receptor distribution on paraformaldehyde-fixed cells 
Cells were sequentially incubated with primary and second-
ary antibodies for 30 min (15 min primary and 15 min sec-
ondary IgG) or 120 min (60 min primary and 60 min second-
ary IgG) on ice. The cells were subsequently fixed in 4% 
paraformaldehyde. The cluster densities in fixed cells were 
similar to the values obtained for live cells at 4°C, i.e. around 
12 clusters per um2 (Fig. 2A). The frequency distribution of 
cluster densities is presented for the 30 min incubation (Fig. 
3B) and is analogous to that for the intact cells at 4°C (Fig. 
3A). The differences in symmetry between these two distribu-
tions may be attributed to the fact that in Fig. 3A, the data 
reflect a range of incubation times over 35 min while the 
paraformaldehyde data (Fig. 3B) is effectively a 'snapshot' 
of the receptor distribution at a single time. However, the 
similarity in the spread of the two 4°C distributions is evident. 
3.3. Effect of serum and tyrosine kinase inhibition on receptor 
distribution 
The experiments involving treatment of the cells with serum 
or erbstatin analog were performed as time series experiments 
in a manner similar to those previously described. However, a 
limited number of time series were run for these experiments. 
To facilitate comparisons, the data were averaged across the 
time series as there was little temporal variation between time 
points at 4 and 37°C (Fig. 2A,B). This allowed for grouped 
comparisons between the data from different experiments 
(Fig. 4), but entailed the loss of any temporal trends con-
tained in the time series. Nevertheless, the smaller number 
of series run for the last two experiments precluded resolution 
of any temporal trends from the data anyway. 
On a limited number of samples, we employed ICS to char-
acterize the 4°C distribution of receptors after adding serum 
at time zero. Interestingly, the cluster density increased fol-
lowing addition of the serum to the samples (Fig. 4). 
A number of samples were pre-treated with an analog of 
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Fig. 1. (A) Overview (low magnification) confocal image of an AG1523 fibroblast showing labeled PDGF-ß receptors. The image has dimen-
sions of 102.4 umX 102.4 um. (B) High magnification 'zoom' image of labeled PDGF-ß receptors sampled from the area enclosed by the white 
square overlay on the cell depicted in (A). The image has dimensions of 25.6 um X 25.6 M-ni. (C) Autocorrelation function with function of best 
fit in near quadrant. This discrete autocorrelation function was calculated from the confocal image shown in (B). The g(0,0) value of this func-
tion is inversely proportional to the number of spatially independent labeled receptors per laser beam focal area. 
the tyrosine kinase inhibitor erbstatin (5 (ig/ml) at 37°C before 
immunolabeling and confocal imaging at 4°C, and an appar-
ent dispersion of receptors was observed via ICS measure-
ments (higher cluster densities; Fig. 4). However, when 
PDGF-BB was added together with the erbstatin analog at 
time 0, the dispersion effect of erbstatin analog was attenuated 
(Fig. 4). 
4. Discussion 
Dimerization and aggregation of PDGF receptors have 
been postulated to play a crucial role in ligand-induced recep-
tor signaling [5,14,15,28]. It is, however, extremely difficult to 
evaluate the degree of dimerization and aggregation by direct 
visual inspection of the distribution of fluorescently tagged 
receptors in the membrane. To address questions of receptor 
aggregation state we recently presented image correlation 
spectroscopy [21], which was initially applied to the distribu-
tion of PDGF receptors in fixed, dermal fibroblasts. That 
approach has now been extended to the study of PDGF-ß 
receptors in living fibroblasts at 4 and 37°C, and under the 
influence of PDGF-BB, serum and erbstatin analog treatment. 
With ICS we can compare the number of receptor clusters 
per unit membrane area on different cell population samples. 
However, absolute quantification of receptor cluster density 
requires experimental control of background fluorescence aris-
ing from autofluorescence and non-specific binding of fluor-
ophore (Wiseman et a l , in preparation). Such controls are 
relatively easy to implement with fixed cell preparations, but 
the nature of the time series measurements on living cells 
precluded inclusion of these controls in the experiments. 
Therefore, the results presented in this report have not been 
corrected for background fluorescence contributions and are 
biased slightly toward higher cluster densities. Although not 
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Fig. 2. Cluster density (per um2) of PDGF-ß receptors at 4 and 
37°C, as assessed with image correlation spectroscopy (ICS): (A) 
average cluster densities ± S.E.M. at 4°C. The separate data points 
represent the average cluster densities of the samples labeled for 120 
min (square) and 30 min (circle) at 4°C with subsequent fixation 
using 4% paraformaldehyde. (B) Average cluster densities ± S.E.M. 
at 37°C. Platelet-derived growth factor (PDGF-BB) was added at 
time zero for both the 4 and 37°C samples. 
accurate in the absolute sense, the cluster densities may be 
used comparatively to demonstrate changes in the underlying 
state of receptor aggregation. Valid comparisons may be made 
between samples measured under identical collection condi-
tions, and this criterion was adhered to in the experiments 
presented in this report. 
The results depicted in Fig. 2A,B show that the receptor 
cluster density is lower by a factor of 3-4- at 37°C as compared 
to 4°C. This reflects an increasingly aggregated receptor dis-
tribution at the higher temperature (fewer clusters containing 
larger numbers of receptor subunits). Also, addition of 
PDGF-BB at time zero caused no detectable change in the 
state of receptor aggregation. Interpretation of the aggrega-
tion at 37°C as an antibody induced effect is consistent with 
the results. Primary and secondary immunolabeling was car-
ried out with whole antibodies which are able to physically 
crosslink receptors due to the bivalent nature of the IgG mol-
ecule. Previous work has demonstrated that the PDGFR-B2 
IgG induces clustering of PDGF-ß receptors [21,26]. The 
change in the receptor aggregation state observed here is 
probably due to rapid crosslinking of the receptors by primary 
and secondary IgG label at 37°C. At 4°C the diffusive mobil-
ity of the receptors is greatly reduced, so addition of the IgG 
label at this temperature cannot lead to antibody induced 
crosslinking of receptors. Consequently, measurements on 
ice effectively sample the underlying receptor distribution 
while antibody induced clustering is only observed when the 
samples are warmed to 37°C (Figs. 2A,B and 4). 
The absence of an effect of PDGF-BB on the receptor ag-
gregation state may be due to the fact that the antibody label 
induces a maximum cross-linking of the receptor subunits and 
the added growth factor binds to the previously clustered 
receptors. Determination of the effect of PDGF-BB by itself 
would require immunolabeling with monovalent Fab frag-
ments to remove any confounding effect of IgG induced clus-
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Fig. 3. Frequency histograms of PDGF-ß receptor cluster densities 
for sample data presented in Fig. 2. (A) Histogram of PDGF-ß re-
ceptor cluster densities for intact cells at 4°C. (B) Frequency histo-
gram of cluster densities of PDGF-ß receptors at 4°C as assessed 
with ICS on cells fixed with 4% paraformaldehyde after 30 min of 
immunolabeling on ice. (C) Cluster density histogram for intact cell 
samples at 37°C. 
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Fig. 4. Summary of mean cluster density data (per um2) averaged 
across the time series for labeled PDGF-ß receptors under various 
treatment conditions. The white bar is the time-independent average 
cluster density for the 37°C samples from times —5 to 30 min. The 
black bar represents the analogous mean value for the 4°C samples 
from times —5 to 30 min. The hatched bar (slanted up from left to 
right) is the average cluster density of the —5 min samples from the 
10% serum experiment (samples at 4°C prior to addition of serum). 
The other hatched bar (slanted down from left to right) is the aver-
age cluster density calculated from the remaining images in the time 
series for the 10% serum experiment: times 0 to 30 min (all samples 
at 4°C after addition of the serum). The cross-hatched bar shows 
the average cluster density calculated from the time series data from 
time 0 to 30 min for the samples treated with erbstatin analog at 
time 0. The bar with the horizontal line fill depicts the average clus-
ter density calculated from the time series data from time 0 to 30 
min for the samples treated with erbstatin analog and PDGF-BB at 
time 0. Note that all samples in the final two experiments had been 
pre-incubated with erbstatin analog at 37°C before immunolabeling 
and confocal imaging were conducted at 4°C. The error bars repre-
sent the S.E.M. while the numbers below the column bars indicate 
the number of images included in the calculation of the average (i.e. 
the number of independent cells sampled). 
tering. However, such an experiment requires ultra-sensitive 
fluorescence detection with the confocal microscope as there is 
a significant reduction in the amount of bound fiuorophore 
when Fab labeling is employed. Photon counting detection 
may be beneficial for faintly labeled samples as would be 
the case for Fab labeling, but this collection mode was not 
available on the instrument used in these experiments. 
Comparison of the results obtained for intact cells at 4°C 
and paraformaldehyde fixed specimens at the same tempera-
ture showed essentially equivalent cluster densities (Figs. 2A 
and 3A,B) This result is significant as it demonstrates that 
paraformaldehyde fixation has no artefactual effect on the 
underlying receptor aggregation state and establishes the 
equivalence of measurements on intact and fixed samples. 
As measurements on fixed specimens are easily implemented, 
more data may be accumulated from fixed preparations allow-
ing more reliable assessments of changes in cell population 
parameters. 
The variation in cluster density among individual cells is 
much greater at 4°C than at 37°C (Fig. 3A,C). This reflects 
a heterogeneous distribution of receptors in clusters of various 
size across the surface of different cells. The distribution in 
cluster density at the lower temperature reflects a direct sam-
pling of the underlying range within the cell population. At 
37°C, the antibody label clusters the more dispersed receptor 
47 
subunits which leads to a concomitant narrowing of the dis-
tribution of detected cluster densities (Fig. 3C). 
Comparison of the grouped data between different experi-
ments (the averages across time series depicted in Fig. 4) al-
lows assessment of global changes in the aggregation state of 
PDGF-ß receptors in the cell population following various 
treatments. Addition of serum to the cells seemed to cause a 
slight dispersion of the receptor population (Fig. 4). Although 
the results were calculated from a small number of samples, 
they are consistent with earlier work on the effect of serum on 
PDGF-ß receptor mobilities [16,17]. As has been noted, addi-
tion of serum increased the diffusion coefficient and mobile 
fraction of PDGF-ß receptors as detected in these FRAP 
studies. If addition of serum does indeed lead to dispersion 
of receptors from aggregates, an increase in mobility would be 
detected if the receptor subunits diffuse more rapidly than the 
larger aggregates. This is an intuitively reasonable assumption 
and demonstrates that the ICS measurements are consistent 
with the earlier FRAP experiments. These preliminary results 
suggest that some component in the serum may disperse re-
ceptor aggregates, but more data is needed to confirm this. 
The erbstatin analog, which is a specific inhibitor of tyro-
sine kinase activity, also appears to further disfavor receptor 
clustering (Fig. 4). It appears as though pre-treatment of the 
cells with the erbstatin analog at 37°C leads to a significant 
dispersion of the receptors, and this underlying dispersed dis-
tribution is effectively sampled by subsequent addition of the 
immunolabel at 4°C (Fig. 4). Interestingly, addition of PDGF-
BB in addition to erbstatin analog at time 0 induces greater 
clustering of the receptors than observed in the presence of the 
kinase inhibitor alone (Fig. 4). This contrasts with the pre-
vious experiments where addition of PDGF-BB had no dis-
cernible effect. A possible explanation is that the erbstatin 
analog completely disperses the receptors from clusters so 
that a uniform distribution of monomeric subunits occurs at 
the surface. In this case, a dimerization event caused by addi-
tion of PDGF-BB would be manifest in an ICS measurement. 
The data show a 40% increase in aggregation for samples 
treated with PDGF-BB in addition to the tyrosine kinase in-
hibitor (Fig. 4). In the other experiments involving addition of 
the growth factor, the receptors were detected in a pre-clus-
tered state. Dimerization of receptor subunits by PDGF-BB 
within existing clusters would not be detectable via ICS meas-
urement as such an event would not change the global aggre-
gation state across the surface of the cell. The pre-clustering of 
receptor subunits may explain why no effect of PDGF-BB was 
detected. 
If the erbstatin analog leads to a complete dispersion of the 
receptor subunits, then the receptors are pre-clustered in ag-
gregates containing on average four subunits at 4°C (tetra-
mers). Based on this assumption, we would estimate that 
the antibody crosslinked aggregates contain on average 12 
receptor subunits (Fig. 4). 
As these results suggest, PDGF-BB and erbstatin analog 
have opposite effects on the distribution of receptors within 
aggregates, and it would be challenging to investigate further 
the combined effects of these compounds. 
It is surprising that the addition of both serum and erbsta-
tin analog/PDGF-BB has a measurable effect on the state of 
receptor aggregation at 4°C, whereas the antibody label has 
no crosslinking effect at this temperature. The reason for this 
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paradoxical effect is unknown and warrants further investiga-
tion. 
To summarize, the present study demonstrates that PDGF-
ß receptors are pre-clustered without ligand addition at 4°C, 
but the extent of clustering varies greatly between cells. This 
evidence of small clusters of PDGF-ß receptors on the cell 
surface raises questions as to the physical nature and biologi-
cal function of these clusters. It was recently reported that 
epidermal growth factor (EGF) receptors were sequestered 
in small domains on the surface of mouse keratinocyte cells 
[29]. The detection of pre-clustered PDGF-ß receptors on in-
tact cells at 4°C provides empirical evidence for membrane 
domain structure on human dermal fibroblasts. At 37°C the 
receptors are further clustered either naturally or by crosslink-
ing effects of the antibody label. Preliminary results show that 
certain agents (serum and erbstatin analog) may act to dis-
perse receptor subunits from aggregates. Further studies will 
be focused on addressing whether further dimerization due to 
PDGF within these clusters occurs and can be detected with 
ICS, and whether the clusters may form reaction centers for 
different ligand-induced cellular responses. 
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